Transarterial Chemoembolization and Radioembolization across Barcelona Clinic Liver Cancer Stages.

about

Transarterial Chemoembolization and Radioembolization across Barcelona Clinic Liver Cancer Stages.

Item

http://www.wikidata.org/entity/Q39349638

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Transarterial Chemoembolizatio ...... na Clinic Liver Cancer Stages.

@en

Transarterial Chemoembolizatio ...... na Clinic Liver Cancer Stages.

@nl

type

Item

label

Transarterial Chemoembolizatio ...... na Clinic Liver Cancer Stages.

@en

Transarterial Chemoembolizatio ...... na Clinic Liver Cancer Stages.

@nl

prefLabel

Transarterial Chemoembolizatio ...... na Clinic Liver Cancer Stages.

@en

Transarterial Chemoembolizatio ...... na Clinic Liver Cancer Stages.

@nl

P1476

Transarterial Chemoembolizatio ...... na Clinic Liver Cancer Stages.

@en

P2093

Amir Noor

http://www.w3.org/2001/XMLSchema#string

Edward Kim

http://www.w3.org/2001/XMLSchema#string

Joseph Titano

http://www.w3.org/2001/XMLSchema#string

P2860

Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system

Management of hepatocellular carcinoma: An update

Sorafenib in advanced hepatocellular carcinoma

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.

P304

109-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0037-1602709

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28579678

http://www.w3.org/2001/XMLSchema#string

P932

5453775

http://www.w3.org/2001/XMLSchema#string